ORIC Pharmaceuticals Operating Expenses | ORIC

Annual Operating Expenses ORIC Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
143 M	143 M	111 M	91.8 M	78.9 M	74.2 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
143 M	74.2 M	107 M

Quarterly Operating Expenses ORIC Pharmaceuticals

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
45.3 M	39.6 M	36.7 M	39.1 M	32.7 M	-	38.3 M	36 M	29 M	-	28.7 M	25 M	25.7 M	-	25.7 M	20.7 M	23.3 M	-	18.5 M	21.1 M	16.6 M	-	25.6 M	11.1 M	9.18 M	-	7.1 M	6.36 M	6.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
45.3 M	6.35 M	24.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Celsion Corporation CLSN	14.7 M	-	-6.63 %	$ 13.9 M	USA
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
Qilian International Holding Group Limited QLI	2.16 M	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
Synthetic Biologics SYN	24.1 M	-	1.32 %	$ 16.2 M	USA
Dynavax Technologies Corporation DVAX	137 M	-	-	$ 2.02 B	USA
BioXcel Therapeutics BTAI	107 M	$ 1.19	5.31 %	$ 14.5 M	USA
Burford Capital Limited BUR	181 M	$ 4.37	0.23 %	$ 958 M	Britain
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
BeyondSpring BYSI	40.3 M	$ 0.84	34.27 %	$ 34.5 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Cerus Corporation CERS	149 M	$ 2.98	4.93 %	$ 568 M	USA
Compugen Ltd. CGEN	32.2 M	$ 2.41	4.17 %	$ 225 M	Israel
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	170 M	-	-	$ 4.9 B	Britain
Завод ДИОД DIOD	249 M	-	-	-	Russia
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Hepion Pharmaceuticals HEPA	4.16 M	-	-18.79 %	$ 39.3 K	USA
ARCA biopharma ABIO	122 M	-	1052.0 %	$ 415 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Champions Oncology CSBR	12.5 M	$ 5.1	2.63 %	$ 70.5 M	USA
Affimed N.V. AFMD	54 M	-	-34.95 %	$ 21.5 M	Germany
AnPac Bio-Medical Science Co., Ltd. ANPC	106 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Adial Pharmaceuticals ADIL	7.8 M	$ 3.98	1.86 %	$ 2.66 M	USA
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
AnaptysBio ANAB	187 M	$ 58.47	4.37 %	$ 1.68 B	USA
Anika Therapeutics ANIK	51.6 M	$ 21.5	1.56 %	$ 308 M	USA
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	214 M	-	-	$ 3.37 B	China
Aurinia Pharmaceuticals AUPH	43.9 M	$ 15.47	1.91 %	$ 2.08 B	Canada
GlycoMimetics GLYC	163 M	-	9357.83 %	$ 1.01 B	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
AVROBIO AVRO	84 M	-	1083.1 %	$ 745 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Bicycle Therapeutics plc BCYC	320 M	$ 3.9	0.24 %	$ 270 M	Britain
Beam Therapeutics BEAM	523 M	$ 26.75	0.91 %	$ 2.65 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 67.36	0.99 %	$ 12.9 B	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada